DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Epigenetic and Epitranscriptomic Control in Prostate Cancer
The initiation of prostate cancer has been long associated with DNA copy-number alter-ations, the loss of specific chromosomal regions and gene fusions, and driver mutations, especially those of the Androgen Receptor. Non-mutational events, particularly DNA and RNA epigenetic dysregulation, are emerging as key players in tumorigenesis. In this review we summarize the molecular changes linked to epigenetic and epitranscriptomic dysregulation in prostate cancer and the role that alterations to DNA and RNA modifications play in the initiation and progression of prostate cancer., This work was funded by the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033 grant PID2019-111692RB-I00. In addition, we acknowledge funding from The Scientific Foundation AECC (LABAE19040BLAN), the University of Salamanca and Fundación Memoria de Samuel Solorzano Barruso (FS/36-2020), and Consejería de Educación de la Junta de Castilla y León (CSI264P20) to S.B., A.M.A-G. was supported by USAL-Santander PhD fellowship. J.L. was supported by The Scientific Foundation AECC predoctoral fellowship (PRDSA19002LÓPE) and the Spanish Ministry of Universities predoctoral fellowship (FPU19/01190). The Instituto de Biología Molecular y Celular del Cancer is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia, co-financed by the Castilla–León autonomous government and the European Regional Development Fund (CLC–2017–01).